Hematologic Cancers

Daratumumab May Improve Bone Metabolism in Relapsed/Refractory Multiple Myeloma

By

Vicki Moore, PhD

Publish Date August 15, 2022

Researchers sought to determine whether treatment with daratumumab may be associated with trends of improved bone turnover.

Study Advances Knowledge Base About Children and Adolescents With Myeloproliferative Neoplasms

By

Jennifer Larson

Publish Date August 10, 2022

The researchers uncovered higher-than-anticipated rates of thrombosis, hemorrhage, and transformation in their real-world cohort of MPN patients.

Online Educational Program Improves Patient Understanding in Myelodysplastic Syndromes

By

Vicki Moore, PhD

Publish Date August 10, 2022

Researchers sought to determine whether an online educational program regarding myelodysplastic syndromes would provide benefits to learners’ understanding of MDS.

Targeted Radiotherapy Remains Important in Pediatric Hodgkin Lymphoma With Slow Early Response to Chemotherapy

By

Lauren Dembeck, PhD

Publish Date August 9, 2022

Researchers sought to assess the importance of radiotherapy in pediatric patients with early‐stage low-risk classical Hodgkin lymphoma.

Response-Adapted Nivolumab Salvage Therapy Safe and Effective in Classical Hodgkin Lymphoma

By

Lauren Dembeck, PhD

Publish Date August 8, 2022

Researchers sought to determine whether response-adapted sequential salvage therapy would be effective in patients with relapsed/refractory classical Hodgkin lymphoma.